Inactive Instrument

Primary Health Care Limited Share Price Australian S.E.

Equities

AU000000PRY5

Healthcare Facilities & Services

Financials

Sales 2024 * 1.71B 1.15B 96.56B Sales 2025 * 1.8B 1.21B 101B Capitalization 1.09B 734M 61.33B
Net income 2024 * -616M -415M -34.69B Net income 2025 * 19M 12.8M 1.07B EV / Sales 2024 * 1.5 x
Net Debt 2024 * 1.49B 1B 83.93B Net Debt 2025 * 1.42B 959M 80.16B EV / Sales 2025 * 1.4 x
P/E ratio 2024 *
-1.83 x
P/E ratio 2025 *
48.8 x
Employees -
Yield 2024 *
-
Yield 2025 *
1.24%
Free-Float 87.63%
More Fundamentals * Assessed data
Dynamic Chart

Latest transcript on Primary Health Care Limited

Managers TitleAgeSince
Chief Executive Officer - 01/23/01
Director of Finance/CFO - 01/20/01
Chief Tech/Sci/R&D Officer - 01/21/01
Members of the board TitleAgeSince
Director/Board Member 67 03/15/03
Chairman 65 25/21/25
Director/Board Member - 31/22/31
More insiders
Healius Limited is a healthcare company. The Company’s segments include Pathology, Imaging and Other. The Pathology segment is a provider of pathology services, including specialty pathology and clinical trials. The Imaging segment provides imaging services from standalone imaging sites, hospitals and medical centers. It has a network of pathology laboratories, collection centers and diagnostic imaging centers. It provides specialty diagnostic services to consumers and their referring practitioners. Its brands include Laverty Pathology, QML Pathology, Dorevitch Pathology, Western Diagnostic Pathology, Genomic Diagnostics, Abbott Pathology, IQ Pathology, Vetnostics, TML Vetnostics, Agilex Biolabs, Lumus Imaging, and others. Its Pathology operates 100 medical laboratories and 2,000 patient collection centers across metropolitan, regional and remote Australia. IQ Pathology is a specialized dermatopathology laboratory that provides comprehensive dermatopathology services Australia wide.
More about the company